VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q39375925 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000122.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q39375925‏
024 ‎‡a 0000-0003-0348-7734‏ ‎‡2 orcid‏
024 ‎‡a 7201538867‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q39375925‏
100 0 ‎‡a Michael Simons‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Michael Simons‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Michael Simons‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
400 0 ‎‡a Michael Simons‏ ‎‡c investigador‏ ‎‡9 es‏
400 0 ‎‡a Michael Simons‏ ‎‡c investigador‏ ‎‡9 ast‏
670 ‎‡a Author's Abnormalities in the regulators of angiogenesis in patients with scleroderma‏
670 ‎‡a Author's Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition‏
670 ‎‡a Author's Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation‏
670 ‎‡a Author's ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.‏
670 ‎‡a Author's Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells‏
670 ‎‡a Author's Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells‏
670 ‎‡a Author's An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty‏
670 ‎‡a Author's An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)‏
670 ‎‡a Author's Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?‏
670 ‎‡a Author's Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia‏
670 ‎‡a Author's Angiogenesis in cardiovascular disease: current status and therapeutic potential.‏
670 ‎‡a Author's Angiogenesis in ischemic heart disease‏
670 ‎‡a Author's Angiogenesis in the human heart: gene and cell therapy.‏
670 ‎‡a Author's Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling‏
670 ‎‡a Author's Angiographic methods to assess human coronary angiogenesis‏
670 ‎‡a Author's Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase‏
670 ‎‡a Author's Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways.‏
670 ‎‡a Author's Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism‏
670 ‎‡a Author's Antiangiogenic plasma activity in patients with systemic sclerosis‏
670 ‎‡a Author's Antisense approach to restenosis‏
670 ‎‡a Author's Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents‏
670 ‎‡a Author's Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis‏
670 ‎‡a Author's atelier académique‏
670 ‎‡a Author's Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a.‏
670 ‎‡a Author's Author Correction: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis‏
670 ‎‡a Author's Auxiliary and Autonomous Proteoglycan Signaling Networks‏
670 ‎‡a Author's Beta-adrenergic modulation of the collateral-dependent coronary microcirculation‏
670 ‎‡a Author's Branching morphogenesis.‏
670 ‎‡a Author's c-Myb function in fibroblasts‏
670 ‎‡a Author's Calling on reserves: granulocyte colony stimulating growth factor in cardiac repair‏
670 ‎‡a Author's Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.‏
670 ‎‡a Author's Cell communications in the heart.‏
670 ‎‡a Author's Chapter 14. Assessment of arteriogenesis‏
670 ‎‡a Author's Characterization of synectin expression and promoter activity‏
670 ‎‡a Author's Chemokine-coupled β2 integrin-induced macrophage Rac2-Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis‏
670 ‎‡a Author's Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.‏
670 ‎‡a Author's Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs‏
670 ‎‡a Author's Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity‏
670 ‎‡a Author's Copper chelation represses the vascular response to injury‏
670 ‎‡a Author's Correlation approach to identify coding regions in DNA sequences‏
670 ‎‡a Author's Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.‏
670 ‎‡a Author's Delayed arteriogenesis in hypercholesterolemic mice‏
670 ‎‡a Author's Diabetic monocyte and vascular endothelial growth factor signaling impairment.‏
670 ‎‡a Author's Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.‏
670 ‎‡a Author's Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models‏
670 ‎‡a Author's Effect of sialyl Lewis‏
670 ‎‡a Author's Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig.‏
670 ‎‡a Author's Effects of cell grafting on coronary remodeling after myocardial infarction.‏
670 ‎‡a Author's Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.‏
670 ‎‡a Author's Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia‏
670 ‎‡a Author's ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis‏
670 ‎‡a Author's Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.‏
670 ‎‡a Author's Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates‏
670 ‎‡a Author's Endothelial cell-dependent regulation of arteriogenesis‏
670 ‎‡a Author's Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome‏
670 ‎‡a Author's Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium‏
670 ‎‡a Author's Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling‏
670 ‎‡a Author's Endothelial nuclear factor-κB-dependent regulation of arteriogenesis and branching‏
670 ‎‡a Author's Endothelial RAF1/ERK activation regulates arterial morphogenesis.‏
670 ‎‡a Author's Endothelial signaling and the molecular basis of arteriovenous malformation‏
670 ‎‡a Author's Endothelial-to-mesenchymal transition drives atherosclerosis progression‏
670 ‎‡a Author's Endothelium as master regulator of organ development and growth.‏
670 ‎‡a Author's Endothelium-driven myocardial growth or nitric oxide at the crossroads.‏
670 ‎‡a Author's Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells‏
670 ‎‡a Author's ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.‏
670 ‎‡a Author's Evolving revascularization approaches for myocardial ischemia‏
670 ‎‡a Author's Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia‏
670 ‎‡a Author's Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway‏
670 ‎‡a Author's Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice‏
670 ‎‡a Author's Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium.‏
670 ‎‡a Author's Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2‏
670 ‎‡a Author's Finite-size effects on long-range correlations: implications for analyzing DNA sequences‏
670 ‎‡a Author's Flow-regulated lymphatic vasculature development and signaling‏
670 ‎‡a Author's Food for starving hearts‏
670 ‎‡a Author's Fox(y) regulators of VEGF receptors‏
670 ‎‡a Author's Fractal landscapes and molecular evolution: modeling the myosin heavy chain gene family‏
670 ‎‡a Author's Fractals in biology and medicine‏
670 ‎‡a Author's FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression‏
670 ‎‡a Author's Gene therapy versus protein-based therapy: a matter of pharmacokinetics‏
670 ‎‡a Author's Gene transfer for angiogenesis in coronary artery disease.‏
670 ‎‡a Author's Generalized Lévy-walk model for DNA nucleotide sequences.‏
670 ‎‡a Author's Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis‏
670 ‎‡a Author's Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization‏
670 ‎‡a Author's High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb.‏
670 ‎‡a Author's Humoral and cellular factors responsible for coronary collateral formation‏
670 ‎‡a Author's Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries‏
670 ‎‡a Author's Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties‏
670 ‎‡a Author's Integrative signaling in angiogenesis.‏
670 ‎‡a Author's Inter-cellular exchange of cellular components via VE-cadherin-dependent trans-endocytosis‏
670 ‎‡a Author's Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease‏
670 ‎‡a Author's Intracoronary basic fibroblast growth factor‏
670 ‎‡a Author's Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.‏
670 ‎‡a Author's Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization‏
670 ‎‡a Author's Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis‏
670 ‎‡a Author's Lacteal junction zippering protects against diet-induced obesity.‏
670 ‎‡a Author's Linguistic features of noncoding DNA sequences.‏
670 ‎‡a Author's Live 3D echo guidance of catheter-based endomyocardial injection‏
670 ‎‡a Author's Long-range correlation properties of coding and noncoding DNA sequences: GenBank analysis.‏
670 ‎‡a Author's Long-range correlations in nucleotide sequences‏
670 ‎‡a Author's Long-range fractal correlations in DNA‏
670 ‎‡a Author's Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein‏
670 ‎‡a Author's Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice‏
670 ‎‡a Author's Lymphatic fate determination: playing RAF with ERK.‏
670 ‎‡a Author's Lymphatic fate specification: an ERK-controlled transcriptional program‏
670 ‎‡a Author's Lymphatics thrive on stress: mechanical force in lymphatic development‏
670 ‎‡a Author's Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis‏
670 ‎‡a Author's Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization.‏
670 ‎‡a Author's Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis‏
670 ‎‡a Author's Micro computed tomography for vascular exploration.‏
670 ‎‡a Author's Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice.‏
670 ‎‡a Author's Molecular basis for proline- and arginine-rich peptide inhibition of proteasome‏
670 ‎‡a Author's Molecular controls of arterial morphogenesis‏
670 ‎‡a Author's Molecular controls of lymphatic VEGFR3 signaling‏
670 ‎‡a Author's Molecular multitasking: statins lead to more arteries, less plaque‏
670 ‎‡a Author's Mosaic organization of DNA nucleotides‏
670 ‎‡a Author's Myb-dependent regulation of thrombospondin 2 expression. Role of mRNA stability‏
670 ‎‡a Author's Myocyte-dependent Regulation of Endothelial Cell Syndecan-4 Expression‏
670 ‎‡a Author's Myosin VI and cardiomyopathy: Left ventricular hypertrophy, fibrosis, and both cardiac and pulmonary vascular endothelial cell defects in the Snell's waltzer mouse‏
670 ‎‡a Author's N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA-dependent neovascularization‏
670 ‎‡a Author's Need glucose to sprout: local metabolic control of angiogenesis‏
670 ‎‡a Author's Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.‏
670 ‎‡a Author's Non-canonical fibroblast growth factor signalling in angiogenesis.‏
670 ‎‡a Author's Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system‏
670 ‎‡a Author's "On-target" cardiac effects of anticancer drugs: lessons from new biology‏
670 ‎‡a Author's Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease‏
670 ‎‡a Author's Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C‏
670 ‎‡a Author's Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha‏
670 ‎‡a Author's Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation‏
670 ‎‡a Author's Physiology. Lymphatics are in my veins‏
670 ‎‡a Author's PKCalpha activates eNOS and increases arterial blood flow in vivo‏
670 ‎‡a Author's Plasminogen and plasmin activity in patients with coronary artery disease‏
670 ‎‡a Author's Post-endocytic sorting of Plexin-D1 controls signal transduction and development of axonal and vascular circuits.‏
670 ‎‡a Author's PR39, a peptide regulator of angiogenesis‏
670 ‎‡a Author's PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2.‏
670 ‎‡a Author's Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse‏
670 ‎‡a Author's Profilin phosphorylation as a VEGFR effector in angiogenesis‏
670 ‎‡a Author's Progress and prospects: cell based regenerative therapy for cardiovascular disease.‏
670 ‎‡a Author's Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity‏
670 ‎‡a Author's Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling‏
670 ‎‡a Author's Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner‏
670 ‎‡a Author's PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells.‏
670 ‎‡a Author's Publisher Correction: N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA-dependent neovascularization‏
670 ‎‡a Author's Recent advances in understanding lymphangiogenesis and metabolism‏
670 ‎‡a Author's Receptor tyrosine kinases endocytosis in endothelium: biology and signaling‏
670 ‎‡a Author's Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO‏
670 ‎‡a Author's Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myo‏
670 ‎‡a Author's Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells‏
670 ‎‡a Author's Regulation of vascular integrity.‏
670 ‎‡a Author's Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia‏
670 ‎‡a Author's Role of angiogenesis in cardiovascular disease: a critical appraisal.‏
670 ‎‡a Author's Role of synectin in lymphatic development in zebrafish and frogs‏
670 ‎‡a Author's Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis‏
670 ‎‡a Author's Selective regulation of arterial branching morphogenesis by synectin‏
670 ‎‡a Author's Serial motion assessment by reference tracking‏
670 ‎‡a Author's Serial motion assessment by reference tracking (SMART): application to detection of local functional impact of chronic myocardial ischemia‏
670 ‎‡a Author's Silky, sticky chimeras-designer VEGFs display their wares‏
670 ‎‡a Author's Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression‏
670 ‎‡a Author's Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins‏
670 ‎‡a Author's State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association‏
670 ‎‡a Author's Statistical and linguistic features of DNA sequences.‏
670 ‎‡a Author's Statistical properties of DNA sequences.‏
670 ‎‡a Author's Stem cell therapies in cardiovascular disease A "realistic" appraisal.‏
670 ‎‡a Author's Subxyphoid access of the normal pericardium: a novel drug delivery technique‏
670 ‎‡a Author's SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis‏
670 ‎‡a Author's Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.‏
670 ‎‡a Author's Syndecan-4 clustering induces cell migration in a PDZ-dependent manner‏
670 ‎‡a Author's Syndecan 4 controls lymphatic vasculature remodeling during mouse embryonic development‏
670 ‎‡a Author's Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling‏
670 ‎‡a Author's Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis‏
670 ‎‡a Author's Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells‏
670 ‎‡a Author's Syndecan 4 regulation of PDK1-dependent Akt activation‏
670 ‎‡a Author's Syndecan-4 signaling at a glance‏
670 ‎‡a Author's Synectin-dependent gene expression in endothelial cells.‏
670 ‎‡a Author's Synectin-dependent regulation of arterial maturation‏
670 ‎‡a Author's Synectin/syndecan-4 regulate coronary arteriolar growth during development.‏
670 ‎‡a Author's Systematic analysis of coding and noncoding DNA sequences using methods of statistical linguistics‏
670 ‎‡a Author's Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth.‏
670 ‎‡a Author's The anti-angiogenic activity of rPAI-1‏
670 ‎‡a Author's The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions.‏
670 ‎‡a Author's The expanding role of neuropilin: regulation of transforming growth factor-β and platelet-derived growth factor signaling in the vasculature‏
670 ‎‡a Author's The impact of clinical data on interpretation of thallium scintigrams.‏
670 ‎‡a Author's The molecular basis of endothelial cell plasticity.‏
670 ‎‡a Author's The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis‏
670 ‎‡a Author's The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction‏
670 ‎‡a Author's Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial‏
670 ‎‡a Author's Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results‏
670 ‎‡a Author's Transcriptional Profiling in Coronary Artery Disease‏
670 ‎‡a Author's Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.‏
670 ‎‡a Author's Up-regulation of thrombospondin-2 in Akt1-null mice contributes to compromised tissue repair due to abnormalities in fibroblast function.‏
670 ‎‡a Author's Vasa vasorum in normal and diseased arteries‏
670 ‎‡a Author's Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.‏
670 ‎‡a Author's Vascular disease in scleroderma: angiogenesis and vascular repair.‏
670 ‎‡a Author's Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways.‏
670 ‎‡a Author's VEGF administration in chronic myocardial ischemia in pigs‏
670 ‎‡a Author's VEGF and restenosis: the rest of the story‏
670 ‎‡a Author's VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis‏
670 ‎‡a Author's VEGF signaling inside vascular endothelial cells and beyond‏
670 ‎‡a Author's VEGFR2 trafficking: speed doesn't kill‏
670 ‎‡a Author's When endothelial cells go rogue‏
670 ‎‡a Author's When it is better to regress: dynamics of vascular pruning.‏
670 ‎‡a Author's wissenschaftliche Werkstatt‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/DNB|1155617304‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/12147266885635482486‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/LC|n 2016187304‏
909 ‎‡a (scopus) 7201538867‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000303487734‏ ‎‡9 1‏
919 ‎‡a phosphorylationofvecadherincontrolsendothelialphenotypesviap120catenincouplingandrac1activation‏ ‎‡A Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation‏ ‎‡9 1‏
919 ‎‡a pkcalphaactivatesenosandincreasesarterialbloodflowinvivo‏ ‎‡A PKCalpha activates eNOS and increases arterial blood flow in vivo‏ ‎‡9 1‏
919 ‎‡a plasminogenandplasminactivityinpatientswithcoronaryarterydisease‏ ‎‡A Plasminogen and plasmin activity in patients with coronary artery disease‏ ‎‡9 1‏
919 ‎‡a postendocyticsortingofplexind1controlssignaltransductionanddevelopmentofaxonalandvascularcircuits‏ ‎‡A Post-endocytic sorting of Plexin-D1 controls signal transduction and development of axonal and vascular circuits.‏ ‎‡9 1‏
919 ‎‡a angiogenesisarteriogenesisanddiabetesparadigmreassessed‏ ‎‡A Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?‏ ‎‡9 1‏
919 ‎‡a anticd11cd18monoclonalantibodyinpatientswithacutemyocardialinfarctionhavingpercutaneoustransluminalcoronaryangioplastythefestivalstudy‏ ‎‡A An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)‏ ‎‡9 1‏
919 ‎‡a anticd11cd18monoclonalantibodyinpatientswithacutemyocardialinfarctionhavingpercutaneoustransluminalcoronaryangioplasty‏ ‎‡A An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty‏ ‎‡9 1‏
919 ‎‡a pr39apeptideregulatorofangiogenesis‏ ‎‡A PR39, a peptide regulator of angiogenesis‏ ‎‡9 1‏
919 ‎‡a amyloidβprecursorproteinappdownregulationaltersactincytoskeletoninteractingproteinsinendothelialcells‏ ‎‡A Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells‏ ‎‡9 1‏
919 ‎‡a amyloidi2precursorproteinappdownregulationaltersactincytoskeletoninteractingproteinsinendothelialcells‏ ‎‡A Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells‏ ‎‡9 1‏
919 ‎‡a pr39inhibitsapoptosisinhypoxicendothelialcellsroleofinhibitorapoptosisprotein2‏ ‎‡A PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2.‏ ‎‡9 1‏
919 ‎‡a probucolpreventsearlycoronaryheartdiseaseanddeathinthehighdensitylipoproteinreceptorsrbiapolipoproteinedoubleknockoutmouse‏ ‎‡A Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse‏ ‎‡9 1‏
919 ‎‡a profilinphosphorylationasavegfreffectorinangiogenesis‏ ‎‡A Profilin phosphorylation as a VEGFR effector in angiogenesis‏ ‎‡9 1‏
919 ‎‡a progressandprospectscellbasedregenerativetherapyforcardiovasculardisease‏ ‎‡A Progress and prospects: cell based regenerative therapy for cardiovascular disease.‏ ‎‡9 1‏
919 ‎‡a prolineandargininerichpeptidesconstituteanovelclassofallostericinhibitorsofproteasomeactivity‏ ‎‡A Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity‏ ‎‡9 1‏
919 ‎‡a alk1signalinginhibitsangiogenesisbycooperatingwiththenotchpathway‏ ‎‡A ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.‏ ‎‡9 1‏
919 ‎‡a adenoviralpr39improvesbloodflowandmyocardialfunctioninapigmodelofchronicmyocardialischemiabyenhancingcollateralformation‏ ‎‡A Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation‏ ‎‡9 1‏
919 ‎‡a protectionagainstmyocardialischemiareperfusioninjurybytheangiogenicmasterswitchproteinpr39genetherapytherolesofhif1alphastabilizationandfgfr1signaling‏ ‎‡A Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling‏ ‎‡9 1‏
919 ‎‡a accelerationofcardiovasculardiseasebyadysfunctionalprostacyclinreceptormutationpotentialimplicationsforcyclooxygenase2inhibition‏ ‎‡A Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition‏ ‎‡9 1‏
919 ‎‡a abnormalitiesintheregulatorsofangiogenesisinpatientswithscleroderma‏ ‎‡A Abnormalities in the regulators of angiogenesis in patients with scleroderma‏ ‎‡9 1‏
919 ‎‡a proteinkinase100pkcdeltaregulatespkcalphaactivityinasyndecan4dependentmanner‏ ‎‡A Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner‏ ‎‡9 1‏
919 ‎‡a ptp1bisaphysiologicregulatorofvascularendothelialgrowthfactorsignalinginendothelialcells‏ ‎‡A PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells.‏ ‎‡9 1‏
919 ‎‡a publishercorrectionnterminalsyndecan2domainselectivelyenhances6oheparansulfatechainssulfationandpromotesvegfadependentneovascularization‏ ‎‡A Publisher Correction: N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA-dependent neovascularization‏ ‎‡9 1‏
919 ‎‡a recentadvancesinunderstandinglymphangiogenesisandmetabolism‏ ‎‡A Recent advances in understanding lymphangiogenesis and metabolism‏ ‎‡9 1‏
919 ‎‡a receptortyrosinekinasesendocytosisinendotheliumbiologyandsignaling‏ ‎‡A Receptor tyrosine kinases endocytosis in endothelium: biology and signaling‏ ‎‡9 1‏
919 ‎‡a reduceddosefibrinolyticaccelerationofstsegmentelevationmyocardialinfarctiontreatmentcoupledwithurgentpercutaneouscoronaryinterventioncomparedtoprimarypercutaneouscoronaryinterventionaloneresultsoftheamico‏ ‎‡A Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO‏ ‎‡9 1‏
919 ‎‡a reduceddosefibrinolyticaccelerationofstsegmentelevationmyocardialinfarctiontreatmentcoupledwithurgentpercutaneouscoronaryinterventioncomparedtoprimarypercutaneouscoronaryinterventionaloneresultsoftheamicoallianceformyo‏ ‎‡A Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myo‏ ‎‡9 1‏
919 ‎‡a regulationofproteinkinasebaktactivityandser473phosphorylationbyproteinkinasecalphainendothelialcells‏ ‎‡A Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells‏ ‎‡9 1‏
919 ‎‡a angiogenesisdependentandindependentphasesofintimalhyperplasia‏ ‎‡A Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia‏ ‎‡9 1‏
919 ‎‡a angiogenesisincardiovasculardiseasecurrentstatusandtherapeuticpotential‏ ‎‡A Angiogenesis in cardiovascular disease: current status and therapeutic potential.‏ ‎‡9 1‏
919 ‎‡a angiogenesisinischemicheartdisease‏ ‎‡A Angiogenesis in ischemic heart disease‏ ‎‡9 1‏
919 ‎‡a angiogenesisinthehumanheartgeneandcelltherapy‏ ‎‡A Angiogenesis in the human heart: gene and cell therapy.‏ ‎‡9 1‏
919 ‎‡a angiogenesisversusarteriogenesisneuropilin1modulationofvegfsignaling‏ ‎‡A Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling‏ ‎‡9 1‏
919 ‎‡a angiographicmethodstoassesshumancoronaryangiogenesis‏ ‎‡A Angiographic methods to assess human coronary angiogenesis‏ ‎‡9 1‏
919 ‎‡a angiopoietin2secretionbyendothelialcellexosomesregulationbythephosphatidylinositol3kinase‏ ‎‡A Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase‏ ‎‡9 1‏
919 ‎‡a angiopoietin2secretionbyendothelialcellexosomesregulationbythephosphatidylinositol3kinasepi3kaktendothelialnitricoxidesynthaseenosandsyndecan4synteninpathways‏ ‎‡A Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways.‏ ‎‡9 1‏
919 ‎‡a antiangiogenicactivityofrpai123promotesvasavasorumregressioninhypercholesterolemicmicethroughaplasmindependentmechanism‏ ‎‡A Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism‏ ‎‡9 1‏
919 ‎‡a antiangiogenicplasmaactivityinpatientswithsystemicsclerosis‏ ‎‡A Antiangiogenic plasma activity in patients with systemic sclerosis‏ ‎‡9 1‏
919 ‎‡a antisenseapproachtorestenosis‏ ‎‡A Antisense approach to restenosis‏ ‎‡9 1‏
919 ‎‡a arteriogenesisnoninvasivequantificationwithmultidetectorrowctangiographyand3dimensionalvolumerenderinginrodents‏ ‎‡A Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents‏ ‎‡9 1‏
919 ‎‡a assessmentofrelativesensitivitiesofnoninvasivetestsforcardiacamyloidosisindocumentedcardiacamyloidosis‏ ‎‡A Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis‏ ‎‡9 1‏
919 ‎‡a atelieracademique‏ ‎‡A atelier académique‏ ‎‡9 1‏
919 ‎‡a attenuationofendotheliumdependentdilationofpigpulmonaryarteriolesaftercardiopulmonarybypassispreventedbymonoclonalantibodytocomplementc5a‏ ‎‡A Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a.‏ ‎‡9 1‏
919 ‎‡a authorcorrectionsumoylationofvegfr2regulatesitsintracellulartraffickingandpathologicalangiogenesis‏ ‎‡A Author Correction: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis‏ ‎‡9 1‏
919 ‎‡a auxiliaryandautonomousproteoglycansignalingnetworks‏ ‎‡A Auxiliary and Autonomous Proteoglycan Signaling Networks‏ ‎‡9 1‏
919 ‎‡a betaadrenergicmodulationofthecollateraldependentcoronarymicrocirculation‏ ‎‡A Beta-adrenergic modulation of the collateral-dependent coronary microcirculation‏ ‎‡9 1‏
919 ‎‡a branchingmorphogenesis‏ ‎‡A Branching morphogenesis.‏ ‎‡9 1‏
919 ‎‡a 100mybfunctioninfibroblasts‏ ‎‡A c-Myb function in fibroblasts‏ ‎‡9 1‏
919 ‎‡a callingonreservesgranulocytecolonystimulatinggrowthfactorincardiacrepair‏ ‎‡A Calling on reserves: granulocyte colony stimulating growth factor in cardiac repair‏ ‎‡9 1‏
919 ‎‡a cardiomyopathyandworsenedischemicheartfailureinsm22αcremediatedneuropilin1nullmicedysregulationofpgc1αandmitochondrialhomeostasis‏ ‎‡A Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.‏ ‎‡9 1‏
919 ‎‡a cellcommunicationsintheheart‏ ‎‡A Cell communications in the heart.‏ ‎‡9 1‏
919 ‎‡a chapter14assessmentofarteriogenesis‏ ‎‡A Chapter 14. Assessment of arteriogenesis‏ ‎‡9 1‏
919 ‎‡a characterizationofsynectinexpressionandpromoteractivity‏ ‎‡A Characterization of synectin expression and promoter activity‏ ‎‡9 1‏
919 ‎‡a chemokinecoupledβ2integrininducedmacrophagerac2myosiniiainteractionregulatesvegfamrnastabilityandarteriogenesis‏ ‎‡A Chemokine-coupled β2 integrin-induced macrophage Rac2-Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis‏ ‎‡9 1‏
919 ‎‡a cleavageofsyndecan4byadamts1provokesdefectsinadhesion‏ ‎‡A Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.‏ ‎‡9 1‏
919 ‎‡a comparisonoftransendocardialandretrogradecoronaryvenousintramyocardialcatheterdeliverysystemsinhealthyandinfarctedpigs‏ ‎‡A Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs‏ ‎‡9 1‏
919 ‎‡a comparisonofvegfdeliverytechniquesoncollateraldependentmicrovascularreactivity‏ ‎‡A Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity‏ ‎‡9 1‏
919 ‎‡a copperchelationrepressesthevascularresponsetoinjury‏ ‎‡A Copper chelation represses the vascular response to injury‏ ‎‡9 1‏
919 ‎‡a correlationapproachtoidentifycodingregionsindnasequences‏ ‎‡A Correlation approach to identify coding regions in DNA sequences‏ ‎‡9 1‏
919 ‎‡a regulationofvascularintegrity‏ ‎‡A Regulation of vascular integrity.‏ ‎‡9 1‏
919 ‎‡a resultsofadoubleblindplacebocontrolledstudytoassessthesafetyofintramuscularinjectionofhepatocytegrowthfactorplasmidtoimprovelimbperfusioninpatientswithcriticallimbischemia‏ ‎‡A Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia‏ ‎‡9 1‏
919 ‎‡a roleofangiogenesisincardiovasculardiseaseacriticalappraisal‏ ‎‡A Role of angiogenesis in cardiovascular disease: a critical appraisal.‏ ‎‡9 1‏
919 ‎‡a roleofsynectininlymphaticdevelopmentinzebrafishandfrogs‏ ‎‡A Role of synectin in lymphatic development in zebrafish and frogs‏ ‎‡9 1‏
919 ‎‡a roleofvenousendothelialcellsindevelopmentalandpathologicangiogenesis‏ ‎‡A Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis‏ ‎‡9 1‏
919 ‎‡a selectiveregulationofarterialbranchingmorphogenesisbysynectin‏ ‎‡A Selective regulation of arterial branching morphogenesis by synectin‏ ‎‡9 1‏
919 ‎‡a serialmotionassessmentbyreferencetracking‏ ‎‡A Serial motion assessment by reference tracking‏ ‎‡9 1‏
919 ‎‡a serialmotionassessmentbyreferencetrackingsmartapplicationtodetectionoflocalfunctionalimpactofchronicmyocardialischemia‏ ‎‡A Serial motion assessment by reference tracking (SMART): application to detection of local functional impact of chronic myocardial ischemia‏ ‎‡9 1‏
919 ‎‡a silkystickychimerasdesignervegfsdisplaytheirwares‏ ‎‡A Silky, sticky chimeras-designer VEGFs display their wares‏ ‎‡9 1‏
919 ‎‡a smoothmusclefgftgfβcrosstalkregulatesatherosclerosisprogression‏ ‎‡A Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression‏ ‎‡9 1‏
919 ‎‡a spatialheterogeneityinvegfinducedvasodilationvegfdilatesmicrovesselsbutnotepicardialandsystemicarteriesandveins‏ ‎‡A Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins‏ ‎‡9 1‏
919 ‎‡a stateoftheartmethodsforevaluationofangiogenesisandtissuevascularizationascientificstatementfromtheamericanheartassociation‏ ‎‡A State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association‏ ‎‡9 1‏
919 ‎‡a statisticalandlinguisticfeaturesofdnasequences‏ ‎‡A Statistical and linguistic features of DNA sequences.‏ ‎‡9 1‏
919 ‎‡a statisticalpropertiesofdnasequences‏ ‎‡A Statistical properties of DNA sequences.‏ ‎‡9 1‏
919 ‎‡a stemcelltherapiesincardiovasculardiseasearealisticappraisal‏ ‎‡A Stem cell therapies in cardiovascular disease A "realistic" appraisal.‏ ‎‡9 1‏
919 ‎‡a subxyphoidaccessofthenormalpericardiumanoveldrugdeliverytechnique‏ ‎‡A Subxyphoid access of the normal pericardium: a novel drug delivery technique‏ ‎‡9 1‏
919 ‎‡a sumoylationofvegfr2regulatesitsintracellulartraffickingandpathologicalangiogenesis‏ ‎‡A SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis‏ ‎‡9 1‏
919 ‎‡a suppressionofrhogactivityismediatedbyasyndecan4synectinrhogdi1complexandisreversedbypkcalphainarac1activationpathway‏ ‎‡A Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.‏ ‎‡9 1‏
919 ‎‡a syndecan4clusteringinducescellmigrationinapdzdependentmanner‏ ‎‡A Syndecan-4 clustering induces cell migration in a PDZ-dependent manner‏ ‎‡9 1‏
919 ‎‡a syndecan4controlslymphaticvasculatureremodelingduringmouseembryonicdevelopment‏ ‎‡A Syndecan 4 controls lymphatic vasculature remodeling during mouse embryonic development‏ ‎‡9 1‏
919 ‎‡a syndecan4isrequiredforendothelialalignmentinflowandatheroprotectivesignaling‏ ‎‡A Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling‏ ‎‡9 1‏
919 ‎‡a syndecan4regulatesfgfr1signalinginendothelialcellsbydirectingmacropinocytosis‏ ‎‡A Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis‏ ‎‡9 1‏
919 ‎‡a syndecan4regulatessubcellularlocalizationofmtorcomplex2andaktactivationinapkcalphadependentmannerinendothelialcells‏ ‎‡A Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells‏ ‎‡9 1‏
919 ‎‡a syndecan4regulationofpdk1dependentaktactivation‏ ‎‡A Syndecan 4 regulation of PDK1-dependent Akt activation‏ ‎‡9 1‏
919 ‎‡a syndecan4signalingataglance‏ ‎‡A Syndecan-4 signaling at a glance‏ ‎‡9 1‏
919 ‎‡a synectindependentgeneexpressioninendothelialcells‏ ‎‡A Synectin-dependent gene expression in endothelial cells.‏ ‎‡9 1‏
919 ‎‡a synectindependentregulationofarterialmaturation‏ ‎‡A Synectin-dependent regulation of arterial maturation‏ ‎‡9 1‏
919 ‎‡a synectinsyndecan4regulatecoronaryarteriolargrowthduringdevelopment‏ ‎‡A Synectin/syndecan-4 regulate coronary arteriolar growth during development.‏ ‎‡9 1‏
919 ‎‡a systematicanalysisofcodingandnoncodingdnasequencesusingmethodsofstatisticallinguistics‏ ‎‡A Systematic analysis of coding and noncoding DNA sequences using methods of statistical linguistics‏ ‎‡9 1‏
919 ‎‡a targetinggipcsynectininpancreaticcancerinhibitstumorgrowth‏ ‎‡A Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth.‏ ‎‡9 1‏
919 ‎‡a antiangiogenicactivityofrpai1‏ ‎‡A The anti-angiogenic activity of rPAI-1‏ ‎‡9 1‏
919 ‎‡a antiangiogenicactivityofrpai123inhibitsfibroblastgrowthfactor2functions‏ ‎‡A The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions.‏ ‎‡9 1‏
919 ‎‡a expandingroleofneuropilinregulationoftransforminggrowthfactorβandplateletderivedgrowthfactorsignalinginthevasculature‏ ‎‡A The expanding role of neuropilin: regulation of transforming growth factor-β and platelet-derived growth factor signaling in the vasculature‏ ‎‡9 1‏
919 ‎‡a impactofclinicaldataoninterpretationofthalliumscintigrams‏ ‎‡A The impact of clinical data on interpretation of thallium scintigrams.‏ ‎‡9 1‏
919 ‎‡a molecularbasisofendothelialcellplasticity‏ ‎‡A The molecular basis of endothelial cell plasticity.‏ ‎‡9 1‏
919 ‎‡a neuropilin1cytoplasmicdomainisrequiredforvegfadependentarteriogenesis‏ ‎‡A The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis‏ ‎‡9 1‏
919 ‎‡a roleofsyndecancytoplasmicdomaininbasicfibroblastgrowthfactordependentsignaltransduction‏ ‎‡A The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction‏ ‎‡9 1‏
919 ‎‡a therapeuticangiogenesisforcriticallimbischemiadesignofthehepatocytegrowthfactortherapeuticangiogenesisclinicaltrial‏ ‎‡A Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial‏ ‎‡9 1‏
919 ‎‡a therapeuticangiogenesiswithbasicfibroblastgrowthfactortechniqueandearlyresults‏ ‎‡A Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results‏ ‎‡9 1‏
919 ‎‡a transcriptionalprofilingincoronaryarterydisease‏ ‎‡A Transcriptional Profiling in Coronary Artery Disease‏ ‎‡9 1‏
919 ‎‡a transmembraneproteinesdnpromotesendothelialvegfsignalingandregulatesangiogenesis‏ ‎‡A Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.‏ ‎‡9 1‏
919 ‎‡a upregulationofthrombospondin2inakt1nullmicecontributestocompromisedtissuerepairduetoabnormalitiesinfibroblastfunction‏ ‎‡A Up-regulation of thrombospondin-2 in Akt1-null mice contributes to compromised tissue repair due to abnormalities in fibroblast function.‏ ‎‡9 1‏
919 ‎‡a vasavasoruminnormalanddiseasedarteries‏ ‎‡A Vasa vasorum in normal and diseased arteries‏ ‎‡9 1‏
919 ‎‡a vascularadaptationtoadysfunctionalendotheliumasaconsequenceofshbdeficiency‏ ‎‡A Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.‏ ‎‡9 1‏
919 ‎‡a vasculardiseaseinsclerodermaangiogenesisandvascularrepair‏ ‎‡A Vascular disease in scleroderma: angiogenesis and vascular repair.‏ ‎‡9 1‏
919 ‎‡a vascularendothelialgrowthfactorandsemaphorininduceneuropilin1endocytosisviaseparatepathways‏ ‎‡A Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways.‏ ‎‡9 1‏
919 ‎‡a vegfadministrationinchronicmyocardialischemiainpigs‏ ‎‡A VEGF administration in chronic myocardial ischemia in pigs‏ ‎‡9 1‏
919 ‎‡a vegfandrestenosistherestofthestory‏ ‎‡A VEGF and restenosis: the rest of the story‏ ‎‡9 1‏
919 ‎‡a vegfreceptor2endocytictraffickingregulatesarterialmorphogenesis‏ ‎‡A VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis‏ ‎‡9 1‏
919 ‎‡a vegfsignalinginsidevascularendothelialcellsandbeyond‏ ‎‡A VEGF signaling inside vascular endothelial cells and beyond‏ ‎‡9 1‏
919 ‎‡a vegfr2traffickingspeeddoesntkill‏ ‎‡A VEGFR2 trafficking: speed doesn't kill‏ ‎‡9 1‏
919 ‎‡a whenendothelialcells5rogue‏ ‎‡A When endothelial cells go rogue‏ ‎‡9 1‏
919 ‎‡a whenitisbettertoregressdynamicsofvascularpruning‏ ‎‡A When it is better to regress: dynamics of vascular pruning.‏ ‎‡9 1‏
919 ‎‡a wissenschaftlichewerkstatt‏ ‎‡A wissenschaftliche Werkstatt‏ ‎‡9 1‏
919 ‎‡a lactealjunctionzipperingprotectsagainstdietinducedobesity‏ ‎‡A Lacteal junction zippering protects against diet-induced obesity.‏ ‎‡9 1‏
919 ‎‡a linguisticfeaturesofnoncodingdnasequences‏ ‎‡A Linguistic features of noncoding DNA sequences.‏ ‎‡9 1‏
919 ‎‡a live3dechoguidanceofcatheterbasedendomyocardialinjection‏ ‎‡A Live 3D echo guidance of catheter-based endomyocardial injection‏ ‎‡9 1‏
919 ‎‡a longrangecorrelationpropertiesofcodingandnoncodingdnasequencesgenbankanalysis‏ ‎‡A Long-range correlation properties of coding and noncoding DNA sequences: GenBank analysis.‏ ‎‡9 1‏
919 ‎‡a longrangecorrelationsinnucleotidesequences‏ ‎‡A Long-range correlations in nucleotide sequences‏ ‎‡9 1‏
919 ‎‡a longrangefractalcorrelationsindna‏ ‎‡A Long-range fractal correlations in DNA‏ ‎‡9 1‏
919 ‎‡a longtermeffectsofsurgicalangiogenictherapywithfibroblastgrowthfactor2protein‏ ‎‡A Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein‏ ‎‡9 1‏
919 ‎‡a intracoronaryadministrationofrecombinanthumanvascularendothelialgrowthfactortopatientswithcoronaryarterydisease‏ ‎‡A Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease‏ ‎‡9 1‏
919 ‎‡a intracoronarybasicfibroblastgrowthfactor‏ ‎‡A Intracoronary basic fibroblast growth factor‏ ‎‡9 1‏
919 ‎‡a intracoronarybasicfibroblastgrowthfactorfgf2inpatientswithsevereischemicheartdiseaseresultsofaphase1openlabeldoseescalationstudy‏ ‎‡A Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.‏ ‎‡9 1‏
919 ‎‡a intramyocardialdeliveryoffgf2incombinationwithradiofrequencytransmyocardialrevascularization‏ ‎‡A Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization‏ ‎‡9 1‏
919 ‎‡a isoformspecificrolesoferk1anderk2inarteriogenesis‏ ‎‡A Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis‏ ‎‡9 1‏
919 ‎‡a lossofsrbiexpressionleadstotheearlyonsetofocclusiveatheroscleroticcoronaryarterydiseasespontaneousmyocardialinfarctionsseverecardiacdysfunctionandprematuredeathinapolipoproteinedeficientmice‏ ‎‡A Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice‏ ‎‡9 1‏
919 ‎‡a lymphaticfatedeterminationplayingrafwitherk‏ ‎‡A Lymphatic fate determination: playing RAF with ERK.‏ ‎‡9 1‏
919 ‎‡a lymphaticfatespecificationanerkcontrolledtranscriptionalprogram‏ ‎‡A Lymphatic fate specification: an ERK-controlled transcriptional program‏ ‎‡9 1‏
919 ‎‡a intercellularexchangeofcellularcomponentsviavecadherindependenttransendocytosis‏ ‎‡A Inter-cellular exchange of cellular components via VE-cadherin-dependent trans-endocytosis‏ ‎‡9 1‏
919 ‎‡a integrativesignalinginangiogenesis‏ ‎‡A Integrative signaling in angiogenesis.‏ ‎‡9 1‏
919 ‎‡a inhibitionoftumorangiogenesisandgrowthbyasmallmoleculemultifgfreceptorblockerwithallostericproperties‏ ‎‡A Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties‏ ‎‡9 1‏
919 ‎‡a inhibitionofinstentrestenosisbyoralcopperchelationinporcinecoronaryarteries‏ ‎‡A Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries‏ ‎‡9 1‏
919 ‎‡a humoralandcellularfactorsresponsibleforcoronarycollateralformation‏ ‎‡A Humoral and cellular factors responsible for coronary collateral formation‏ ‎‡9 1‏
919 ‎‡a highresolutionquantitativecomputedtomographydemonstratingselectiveenhancementofmediumsizecollateralsbyplacentalgrowthfactor1inthemouseischemichindlimb‏ ‎‡A High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb.‏ ‎‡9 1‏
919 ‎‡a heterozygousdeficiencyofphd2restorestumoroxygenationandinhibitsmetastasisviaendothelialnormalization‏ ‎‡A Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization‏ ‎‡9 1‏
919 ‎‡a heterogeneityamongriptag2insulinomasallowsvascularendothelialgrowthfactoraindependenttumorexpansionasrevealedbystudiesinshbmutantmiceimplicationsfortumorangiogenesis‏ ‎‡A Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis‏ ‎‡9 1‏
919 ‎‡a generalizedlevywalkmodelfordnanucleotidesequences‏ ‎‡A Generalized Lévy-walk model for DNA nucleotide sequences.‏ ‎‡9 1‏
919 ‎‡a lymphaticsthriveonstressmechanicalforceinlymphaticdevelopment‏ ‎‡A Lymphatics thrive on stress: mechanical force in lymphatic development‏ ‎‡9 1‏
919 ‎‡a genetransferforangiogenesisincoronaryarterydisease‏ ‎‡A Gene transfer for angiogenesis in coronary artery disease.‏ ‎‡9 1‏
919 ‎‡a frs2viafibroblastgrowthfactorreceptor1isrequiredforplateletderivedgrowthfactorreceptorbetamediatedregulationofvascularsmoothmusclemarkergeneexpression‏ ‎‡A FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression‏ ‎‡9 1‏
919 ‎‡a fractalsinbiologyandmedicine‏ ‎‡A Fractals in biology and medicine‏ ‎‡9 1‏
919 ‎‡a fractallandscapesandmolecularevolutionmodelingthemyosinheavychaingenefamily‏ ‎‡A Fractal landscapes and molecular evolution: modeling the myosin heavy chain gene family‏ ‎‡9 1‏
919 ‎‡a foxyregulatorsofvegfreceptors‏ ‎‡A Fox(y) regulators of VEGF receptors‏ ‎‡9 1‏
919 ‎‡a foodforstarvinghearts‏ ‎‡A Food for starving hearts‏ ‎‡9 1‏
919 ‎‡a flowregulatedlymphaticvasculaturedevelopmentandsignaling‏ ‎‡A Flow-regulated lymphatic vasculature development and signaling‏ ‎‡9 1‏
919 ‎‡a physiologylymphaticsareinmyveins‏ ‎‡A Physiology. Lymphatics are in my veins‏ ‎‡9 1‏
919 ‎‡a finitesizeeffectsonlongrangecorrelationsimplicationsforanalyzingdnasequences‏ ‎‡A Finite-size effects on long-range correlations: implications for analyzing DNA sequences‏ ‎‡9 1‏
919 ‎‡a fibroblastgrowthfactorsignalingpotentiatesvecadherinstabilityatadherensjunctionsbyregulatingshp2‏ ‎‡A Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2‏ ‎‡9 1‏
919 ‎‡a fibroblastgrowthfactorreceptor1isakeyinhibitoroftgfβsignalingintheendothelium‏ ‎‡A Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium.‏ ‎‡9 1‏
919 ‎‡a fibroblastgrowthfactor2isrequiredforvasavasorumplexusstabilityinhypercholesterolemicmice‏ ‎‡A Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice‏ ‎‡9 1‏
919 ‎‡a fibroblastgrowthfactor2endocytosisinendothelialcellsproceedviasyndecan4dependentactivationofrac1andacdc42dependentmacropinocyticpathway‏ ‎‡A Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway‏ ‎‡9 1‏
919 ‎‡a expressionofvascularendothelialgrowthfactoranditsreceptorsisincreasedbutmicrovascularrelaxationisimpairedinpatientsafteracutemyocardialischemia‏ ‎‡A Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia‏ ‎‡9 1‏
919 ‎‡a evolvingrevascularizationapproachesformyocardialischemia‏ ‎‡A Evolving revascularization approaches for myocardial ischemia‏ ‎‡9 1‏
919 ‎‡a erk12akt1crosstalkregulatesarteriogenesisinmiceandzebrafish‏ ‎‡A ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.‏ ‎‡9 1‏
919 ‎‡a enhancementofmigrationbyproteinkinasecalphaandinhibitionofproliferationandcellcycleprogressionbyproteinkinasecdeltaincapillaryendothelialcells‏ ‎‡A Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells‏ ‎‡9 1‏
919 ‎‡a endotheliumdrivenmyocardialgrowthornitricoxideatthecrossroads‏ ‎‡A Endothelium-driven myocardial growth or nitric oxide at the crossroads.‏ ‎‡9 1‏
919 ‎‡a endotheliumasmasterregulatoroforgandevelopmentandgrowth‏ ‎‡A Endothelium as master regulator of organ development and growth.‏ ‎‡9 1‏
919 ‎‡a endothelialtomesenchymaltransitiondrivesatherosclerosisprogression‏ ‎‡A Endothelial-to-mesenchymal transition drives atherosclerosis progression‏ ‎‡9 1‏
919 ‎‡a endothelialsignalingandthemolecularbasisofarteriovenousmalformation‏ ‎‡A Endothelial signaling and the molecular basis of arteriovenous malformation‏ ‎‡9 1‏
919 ‎‡a endothelialraf1erkactivationregulatesarterialmorphogenesis‏ ‎‡A Endothelial RAF1/ERK activation regulates arterial morphogenesis.‏ ‎‡9 1‏
919 ‎‡a endothelialnuclearfactorκbdependentregulationofarteriogenesisandbranching‏ ‎‡A Endothelial nuclear factor-κB-dependent regulation of arteriogenesis and branching‏ ‎‡9 1‏
919 ‎‡a endothelialmir1792clusternegativelyregulatesarteriogenesisviamirna19repressionofwntsignaling‏ ‎‡A Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling‏ ‎‡9 1‏
919 ‎‡a endothelialerk12signalingmaintainsintegrityofthequiescentendothelium‏ ‎‡A Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium‏ ‎‡9 1‏
919 ‎‡a endothelialdeletionofmurinejag1leadstovalvecalcificationandcongenitalheartdefectsassociatedwithalagillesyndrome‏ ‎‡A Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome‏ ‎‡9 1‏
919 ‎‡a endothelialcelldependentregulationofarteriogenesis‏ ‎‡A Endothelial cell-dependent regulation of arteriogenesis‏ ‎‡9 1‏
919 ‎‡a endothelialakt1mediatesangiogenesisbyphosphorylatingmultipleangiogenicsubstrates‏ ‎‡A Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates‏ ‎‡9 1‏
919 ‎‡a embryoniccoronaryvasculogenesisandangiogenesisareregulatedbyinteractionsbetweenmultiplefgfsandvegfandareinfluencedbymesenchymalstemcells‏ ‎‡A Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.‏ ‎‡9 1‏
919 ‎‡a elavl1regulatesalternativesplicingofeif4etransportertopromotepostnatalangiogenesis‏ ‎‡A ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis‏ ‎‡9 1‏
919 ‎‡a efficacyofintracoronaryversusintravenousfgf2inapigmodelofchronicmyocardialischemia‏ ‎‡A Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia‏ ‎‡9 1‏
919 ‎‡a efficacyofintracoronaryorintravenousvegf165inapigmodelofchronicmyocardialischemia‏ ‎‡A Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.‏ ‎‡9 1‏
919 ‎‡a effectsofcellgraftingoncoronaryremodelingaftermyocardialinfarction‏ ‎‡A Effects of cell grafting on coronary remodeling after myocardial infarction.‏ ‎‡9 1‏
919 ‎‡a effectofsialyllewis10oligosaccharideonmyocardialandcerebralinjuryinthepig‏ ‎‡A Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig.‏ ‎‡9 1‏
919 ‎‡a effectofsialyllewis‏ ‎‡A Effect of sialyl Lewis‏ ‎‡9 1‏
919 ‎‡a dll4notchsignalingdeterminestheformationofnativearterialcollateralnetworksandarterialfunctioninmouseischemiamodels‏ ‎‡A Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models‏ ‎‡9 1‏
919 ‎‡a divergentangiocrinesignalsfromvascularnichebalanceliverregenerationandfibrosis‏ ‎‡A Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.‏ ‎‡9 1‏
919 ‎‡a diabeticmonocyteandvascularendothelialgrowthfactorsignalingimpairment‏ ‎‡A Diabetic monocyte and vascular endothelial growth factor signaling impairment.‏ ‎‡9 1‏
919 ‎‡a delayedarteriogenesisinhypercholesterolemicmice‏ ‎‡A Delayed arteriogenesis in hypercholesterolemic mice‏ ‎‡9 1‏
919 ‎‡a macrophageskewingbyphd2haplodeficiencypreventsischaemiabyinducingarteriogenesis‏ ‎‡A Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis‏ ‎‡9 1‏
919 ‎‡a magneticresonanceimagingdemonstratesimprovedregionalsystolicwallmotionandthickeningandmyocardialperfusionofmyocardialterritoriestreatedbylasermyocardialrevascularization‏ ‎‡A Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization.‏ ‎‡9 1‏
919 ‎‡a medicalimagingtechniquesintheevaluationofstrategiesfortherapeuticangiogenesis‏ ‎‡A Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis‏ ‎‡9 1‏
919 ‎‡a microcomputedtomographyforvascularexploration‏ ‎‡A Micro computed tomography for vascular exploration.‏ ‎‡9 1‏
919 ‎‡a modulationofmicrovascularsignalingbyheparansulfatematrixstudiesinsyndecan4transgenicmice‏ ‎‡A Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice.‏ ‎‡9 1‏
919 ‎‡a currentconceptsinnormalanddefectiveangiogenesisimplicationsforsystemicsclerosis‏ ‎‡A Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.‏ ‎‡9 1‏
919 ‎‡a molecularbasisforprolineandargininerichpeptideinhibitionofproteasome‏ ‎‡A Molecular basis for proline- and arginine-rich peptide inhibition of proteasome‏ ‎‡9 1‏
919 ‎‡a molecularcontrolsofarterialmorphogenesis‏ ‎‡A Molecular controls of arterial morphogenesis‏ ‎‡9 1‏
919 ‎‡a molecularcontrolsoflymphaticvegfr3signaling‏ ‎‡A Molecular controls of lymphatic VEGFR3 signaling‏ ‎‡9 1‏
919 ‎‡a molecularmultitaskingstatinsleadtomorearterieslessplaque‏ ‎‡A Molecular multitasking: statins lead to more arteries, less plaque‏ ‎‡9 1‏
919 ‎‡a mosaicorganizationofdnanucleotides‏ ‎‡A Mosaic organization of DNA nucleotides‏ ‎‡9 1‏
919 ‎‡a mybdependentregulationofthrombospondin2expressionroleofmrnastability‏ ‎‡A Myb-dependent regulation of thrombospondin 2 expression. Role of mRNA stability‏ ‎‡9 1‏
919 ‎‡a myocytedependentregulationofendothelialcellsyndecan4expression‏ ‎‡A Myocyte-dependent Regulation of Endothelial Cell Syndecan-4 Expression‏ ‎‡9 1‏
919 ‎‡a myosin6andcardiomyopathyleftventricularhypertrophyfibrosisandbothcardiacandpulmonaryvascularendothelialcelldefectsinthesnellswaltzermouse‏ ‎‡A Myosin VI and cardiomyopathy: Left ventricular hypertrophy, fibrosis, and both cardiac and pulmonary vascular endothelial cell defects in the Snell's waltzer mouse‏ ‎‡9 1‏
919 ‎‡a nterminalsyndecan2domainselectivelyenhances6oheparansulfatechainssulfationandpromotesvegfadependentneovascularization‏ ‎‡A N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA-dependent neovascularization‏ ‎‡9 1‏
919 ‎‡a needglucosetosproutlocalmetaboliccontrolofangiogenesis‏ ‎‡A Need glucose to sprout: local metabolic control of angiogenesis‏ ‎‡9 1‏
919 ‎‡a neuropilin1vegfr2complexingrequiresthepdzbindingdomainofneuropilin1‏ ‎‡A Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.‏ ‎‡9 1‏
919 ‎‡a noncanonicalfibroblastgrowthfactorsignallinginangiogenesis‏ ‎‡A Non-canonical fibroblast growth factor signalling in angiogenesis.‏ ‎‡9 1‏
919 ‎‡a nonequilibriumdynamicsasanindispensablecharacteristicofahealthybiologicalsystem‏ ‎‡A Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system‏ ‎‡9 1‏
919 ‎‡a ontargetcardiaceffectsofanticancerdrugslessonsfromnewbiology‏ ‎‡A "On-target" cardiac effects of anticancer drugs: lessons from new biology‏ ‎‡9 1‏
919 ‎‡a genetherapyversusproteinbasedtherapyamatterofpharmacokinetics‏ ‎‡A Gene therapy versus protein-based therapy: a matter of pharmacokinetics‏ ‎‡9 1‏
919 ‎‡a pharmacokineticsandpharmacodynamicsofrecombinantfgf2inaphase1trialincoronaryarterydisease‏ ‎‡A Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease‏ ‎‡9 1‏
919 ‎‡a phosphatidylinositol45bisphosphatemediatestheinteractionofsyndecan4withproteinkinase100‏ ‎‡A Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C‏ ‎‡9 1‏
919 ‎‡a phosphorylationofthecytoplasmictailofsyndecan4regulatesactivationofproteinkinasecalpha‏ ‎‡A Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 2003114679‏
996 ‎‡2 LC|n 2016052898‏
996 ‎‡2 NTA|151809615‏
996 ‎‡2 LC|no2019088936‏
996 ‎‡2 DNB|1165106930‏
996 ‎‡2 J9U|987007315307905171‏
996 ‎‡2 BIBSYS|1032437‏
996 ‎‡2 ISNI|0000000043427910‏
996 ‎‡2 NSK|000185637‏
996 ‎‡2 NTA|437856143‏
996 ‎‡2 RERO|A003833827‏
996 ‎‡2 NTA|32829926X‏
996 ‎‡2 DNB|118017330‏
996 ‎‡2 ISNI|0000000389802802‏
996 ‎‡2 ISNI|000000001095970X‏
996 ‎‡2 DNB|120956802‏
996 ‎‡2 NTA|331234017‏
996 ‎‡2 NTA|068788959‏
996 ‎‡2 J9U|987007456577705171‏
996 ‎‡2 ISNI|0000000117448977‏
996 ‎‡2 PLWABN|9813610083605606‏
996 ‎‡2 J9U|987007317164905171‏
996 ‎‡2 ISNI|000000039103032X‏
996 ‎‡2 SUDOC|256303037‏
996 ‎‡2 NLA|000035445000‏
996 ‎‡2 LC|no 00046729‏
996 ‎‡2 LC|no2020030869‏
996 ‎‡2 ISNI|0000000397175239‏
996 ‎‡2 LNB|LNC10-000127326‏
996 ‎‡2 LC|no2010073483‏
996 ‎‡2 NTA|148045995‏
996 ‎‡2 LC|n 2001145627‏
996 ‎‡2 ISNI|0000000048494266‏
996 ‎‡2 NUKAT|n 2004258790‏
996 ‎‡2 ISNI|0000000391567178‏
996 ‎‡2 JPG|500031588‏
996 ‎‡2 LC|n 87139200‏
996 ‎‡2 ISNI|0000000501274289‏
996 ‎‡2 DNB|1074023102‏
996 ‎‡2 LC|no2005098390‏
996 ‎‡2 LC|n 87107985‏
996 ‎‡2 ISNI|0000000063770759‏
996 ‎‡2 BNF|14604437‏
996 ‎‡2 ISNI|0000000032571220‏
996 ‎‡2 DNB|1158501552‏
996 ‎‡2 ISNI|0000000397766725‏
996 ‎‡2 SUDOC|13540682X‏
996 ‎‡2 DNB|1051012333‏
996 ‎‡2 DNB|123263301‏
996 ‎‡2 NTA|131931407‏
996 ‎‡2 DNB|1175587222‏
996 ‎‡2 RERO|A027700792‏
996 ‎‡2 J9U|987007297064005171‏
996 ‎‡2 NTA|070084998‏
996 ‎‡2 LC|n 2023181412‏
996 ‎‡2 ISNI|0000000020146809‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Simons, Michael,‏ ‎‡c MD‏ ‎‡2 LC|n 2016187304‏ ‎‡3 title: (0.74, 'fibroblastgrowthfactors', 'intracoronarybasicfibroblastgrowthfactor')‏ ‎‡3 suggested‏
998 ‎‡a Simons, Michael‏ ‎‡2 DNB|1155617304‏ ‎‡3 suggested‏ ‎‡3 standard number‏